Product
Induction Phase1
1 clinical trial
2 indications
Indication
lymphomaIndication
LymphoblasticClinical trial
Modified BFM-95 Regimen for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults:a Prospective Phase II StudyStatus: Recruiting, Estimated PCD: 2025-03-01